One MORE for Chronic Pain

Overseen By Carter Minnick, BA

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Utah

Disqualifiers: Non Spanish-speaking, Psychotic episode, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

Duration: 6 weeks

34 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will be a single-site, two-arm randomized controlled trial conducted among Spanish-speaking chronic pain patients. Chronic pain patients will be randomized by a computer-generated randomization schedule with simple random allocation (1:1) to either One MORE or a wait-list control condition (WLC). One MORE will be delivered individually either in-person or via a HIPAA compliant virtual meeting platform.

Eligibility Criteria

This trial is for Spanish-speaking individuals experiencing chronic pain. Participants will be chosen randomly to either receive the One MORE program or be placed on a wait-list control group. The study requires participants to have consistent access to in-person meetings or a secure virtual platform.

Inclusion Criteria

I speak Spanish.

Willingness to participate in study interventions and assessments.

I have been diagnosed with a long-term pain condition.

Exclusion Criteria

Presence of clinically unstable illness judged to interfere with treatment or study procedures

I do not speak Spanish.

Psychotic episode within the last 12 months as deemed by the corresponding subsection of the MINI

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the One MORE intervention individually either in-person or via a HIPAA compliant virtual meeting platform

6 weeks

2 visits (in-person or virtual)

Follow-up

Participants are monitored for changes in anxiety, pain, and well-being after treatment

6 weeks

Treatment Details

Interventions

• One MORE (Spanish Adaptation)

Trial Overview The trial is testing the effectiveness of 'One MORE', which is adapted for Spanish speakers, in managing chronic pain compared to not receiving immediate treatment (wait-list). It's a randomized study meaning people are put into groups by chance.

Participant Groups

Group I: One MORE (Spanish Adaptation) Experimental Treatment 1 Intervention

Group II: Waitlist Control Active Control 1 Intervention

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials

1,169

Recruited

1,623,000+